Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.

Experimental allergic encephalomyelitis is a T-cell-mediated, major histocompatibility complex (MHC) class II gene-linked autoimmune demyelinating disease of the central nervous system. To develop therapies that will specifically inactivate only the autoantigen-reactive T cells, mice were treated wi...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Sharma, S D, Nag, B, Su, X M, Green, D, Spack, E, Clark, B R, Sriram, S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1991
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC53156/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1722335/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.88.24.11465
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!